ZNF460-AS1
gene geneOn this page
Summary
ZNF460-AS1 (ZNF460 antisense RNA 1, HGNC:53774) is a long non-coding RNA gene on chromosome 19q13.43.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:53774 |
| Approved symbol | ZNF460-AS1 |
| Name | ZNF460 antisense RNA 1 |
| Location | 19q13.43 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Ensembl gene | ENSG00000267871 |
| Ensembl biotype | lncRNA |
| Entrez | 105372476 |
| RNAcentral | URS0000A773C1 — lncRNA, 782 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 12 — 12 lncRNA
ENST00000597601, ENST00000601567, ENST00000669944, ENST00000671172, ENST00000804658, ENST00000804659, ENST00000804660, ENST00000804661, ENST00000804662, ENST00000804663, ENST00000804664, ENST00000804665
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000597601 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003003388 | 57276935 | 57277056 |
| ENSE00004196157 | 57267188 | 57267712 |
| ENSE00004196167 | 57280279 | 57280412 |
Expression profiles
Bgee: expression breadth ubiquitous, 134 present calls, max score 95.34.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0565 / max 10.3419, expressed in 25 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 208948 | 0.0565 | 25 |
Top tissues by expression
136 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| thymus | UBERON:0002370 | 95.34 | gold quality |
| cerebellar vermis | UBERON:0004720 | 86.19 | gold quality |
| quadriceps femoris | UBERON:0001377 | 82.28 | gold quality |
| right uterine tube | UBERON:0001302 | 76.07 | gold quality |
| gastrocnemius | UBERON:0001388 | 76.02 | gold quality |
| muscle of leg | UBERON:0001383 | 75.55 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 73.72 | gold quality |
| nucleus accumbens | UBERON:0001882 | 73.66 | gold quality |
| thyroid gland | UBERON:0002046 | 73.53 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 73.39 | gold quality |
| pituitary gland | UBERON:0000007 | 73.11 | gold quality |
| putamen | UBERON:0001874 | 72.66 | gold quality |
| adenohypophysis | UBERON:0002196 | 72.64 | gold quality |
| caudate nucleus | UBERON:0001873 | 72.36 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 71.93 | gold quality |
| prostate gland | UBERON:0002367 | 71.92 | gold quality |
| substantia nigra | UBERON:0002038 | 71.89 | gold quality |
| lower esophagus | UBERON:0013473 | 71.89 | gold quality |
| popliteal artery | UBERON:0002250 | 71.87 | gold quality |
| tibial artery | UBERON:0007610 | 71.85 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 71.83 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 71.82 | gold quality |
| apex of heart | UBERON:0002098 | 71.76 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 71.61 | gold quality |
| amygdala | UBERON:0001876 | 71.53 | gold quality |
| Ammon’s horn | UBERON:0001954 | 71.42 | gold quality |
| temporal lobe | UBERON:0001871 | 71.40 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 71.35 | gold quality |
| islet of Langerhans | UBERON:0000006 | 71.20 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 71.13 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.69 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.